Literature DB >> 744080

The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide.

S W Lamberts, R M MacLeod.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 744080     DOI: 10.1210/endo-103-1-287

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  13 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

Review 2.  Control of prolactin secretion by excitatory amino acids.

Authors:  György M Nagy; Ibolya Bodnár; Zsuzsanna Bánky; Béla Halász
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 3.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

4.  Neuroleptic-induced prolactin rise: influence of pharmacological alterations of different neurotransmitter system.

Authors:  T Chieli; D Cocchi; G B Fregnan; E E Müller
Journal:  Experientia       Date:  1980-04-15

5.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  The weight gain and ultimate adiposity in cafeteria diet-induced obesity is unrelated to the central serotoninergic tonus.

Authors:  J De Schepper; X Zhou; O Louis; B Velkeniers; E Hooghe-Peters; L Vanhaelst
Journal:  Eat Weight Disord       Date:  1997-03       Impact factor: 4.652

Review 7.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

8.  The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.

Authors:  D S Charney; G R Heninger; J F Reinhard; D E Sternberg; K M Hafstead
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects.

Authors:  D S Charney; G R Heninger; J F Reinhard; D E Sternberg; K M Hafstead
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.

Authors:  E Flückiger; U Briner; H R Bürki; P Marbach; H R Wagner; W Doepfner
Journal:  Experientia       Date:  1979-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.